Inactive Instrument

Press Releases ZIVO Bioscience, Inc. Other OTC

Equities

ZIVO

US98978N1019

Press Releases

Unlock all the news: Be the first to know and act before the market!

ZIVO BIOS : Quarterly Results (Excel)	May. 13	PU
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	Feb. 07	BU
ZIVO Bioscience Announces Uplisting to OTCQB Market	Jan. 29	BU
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23-10-30	BU
ZIVO Bioscience Announces Reverse Stock Split	23-10-26	BU
ZIVO Bioscience : Dawon James Small Cap Growth Conference Presentation	23-10-12	PU
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference	23-10-03	GL
Trial Results Confirm Efficacy of ZIVO Bioscience's Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23-09-20	AQ
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23-09-19	BU
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife Algal Biomass Product Produced Over the Next 18 Months	23-08-17	AQ
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months	23-08-16	BU
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food	23-07-26	BU
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market	23-07-03	AQ
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market	23-06-30	BU
ZIVO Bioscience : Submission of Matters to a Vote of Security Holders - Form 8-K	23-06-16	PU
ZIVO's GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient	23-05-31	AQ
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient	23-05-30	BU
ZIVO Bioscience : Failure to Satisfy Listing Rule - Form 8-K	23-05-26	PU
ZIVO BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	23-04-05	AQ
ZIVO Bioscience Receives $1 Million Bridge Financing	23-04-05	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ZIVO Bioscience, Inc. Other OTC

Equities

ZIVO

US98978N1019

Press Releases

Filters